HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Effects of second and third generation oral contraceptives on hemostasis].

Abstract
Use of oral contraceptives induce changes in haemostatic parameters: changes occur in the procoagulant, anticoagulant, and fibrinolytic systems. The increased risk of venous thromboembolism with use of third, as compared with second generation oral contraceptives, found in epidemiological studies, has stimulated new research in haemostatic changes induced by both generations of oral contraceptives. A randomized crossover study showed that use of the third generation pill caused a greater increase of factor VII and prothrombin and a more pronounced decrease of factor V than the second generation pill. Acquired resistance to activated protein C (APC) was induced more strongly by preparations of the third than by those of the second generation. The concentration of protein S decreased markedly exclusively during use of the third generation pill, while it did not change during use of the second generation pill. The oral contraception-related effects on the anticoagulant system strongly resemble those of some forms of hereditary thrombophilia. If a woman with hereditary APC resistance (caused by factor V Leiden) uses oral contraceptives as well, and especially when she uses those of the third generation, she is subject to a considerable increase of the risk of venous thrombosis and becomes even more resistant to the anticoagulant action of protein C. In view of the epidemiological backgrounds of the difference in risk of thrombosis between second and third generation contraceptives, the second generation pill is recommended as the first choice for oral contraception.
AuthorsS Middeldorp, J Rosing, B N Bouma, H R Büller
JournalNederlands tijdschrift voor geneeskunde (Ned Tijdschr Geneeskd) Vol. 145 Issue 6 Pg. 252-6 (Feb 10 2001) ISSN: 0028-2162 [Print] Netherlands
Vernacular TitleEffecten van orale anticonceptiva van de tweede en de derde generatie op de hemostase.
PMID11236370 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Blood Coagulation Factors
  • Contraceptives, Oral
  • Protein S
  • Factor V
  • Factor VII
  • Prothrombin
Topics
  • Activated Protein C Resistance (complications)
  • Blood Coagulation Factors (drug effects)
  • Coagulation Protein Disorders (complications)
  • Contraceptives, Oral (adverse effects, classification, contraindications)
  • Cross-Over Studies
  • Factor V (drug effects)
  • Factor VII (drug effects)
  • Female
  • Hemostasis (drug effects)
  • Humans
  • Netherlands
  • Practice Guidelines as Topic
  • Protein S (drug effects)
  • Prothrombin (drug effects)
  • Randomized Controlled Trials as Topic
  • Venous Thrombosis (chemically induced, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: